{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:02:49Z","timestamp":1785816169883,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1164,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008782","name":"Sociedad Espa\u00f1ola de Hematolog\u00eda y Hemoterapia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009093","name":"Fundaci\u00f3n Espa\u00f1ola de Hematolog\u00eda y Hemoterapia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.exphem.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T02:58:49Z","timestamp":1551063529000},"page":"9-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains"],"prefix":"10.1016","volume":"72","author":[{"given":"Mar\u00eda","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Eugenia","family":"Rodr\u00edguez-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gonz\u00e1lez-Gasc\u00f3n y Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Quijada-\u00c1lamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Mar\u00eda","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mart\u00edn-Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Mar\u00eda","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2019.02.003_bib0001","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2019.02.003_bib0002","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.leu.2403586","article-title":"Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma","volume":"19","author":"Wuilleme","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2019.02.003_bib0003","first-page":"22","article-title":"Hyperdiploidy in CLL\/SLL: A rare cytogenetic event associated with poor prognosis","volume":"40","author":"DeNicola","year":"2014","journal-title":"J Am Assoc Gene Technologists"},{"key":"10.1016\/j.exphem.2019.02.003_bib0004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/ejh.12812","article-title":"Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL","volume":"98","author":"Gonzalez-Gascon","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2019.02.003_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/0019-509X.84937","article-title":"A rare case of B-cell chronic lymphocytic leukemia with t(2;14)(p13;q32), +X, +11, +12, +13,+der(1p) karyotype","volume":"48","author":"Vundinti","year":"2011","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.exphem.2019.02.003_bib0006","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.0141-9854.2003.00574.x","article-title":"Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene","volume":"26","author":"Watanabe","year":"2004","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.exphem.2019.02.003_bib0007","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2019.02.003_bib0008","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2019.02.003_bib0009","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2019.02.003_bib0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows\u2013Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.exphem.2019.02.003_bib0011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2019.02.003_bib0012","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2019.02.003_bib0013","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3109\/10428194.2012.742525","article-title":"BRAF mutations in chronic lymphocytic leukemia","volume":"54","author":"Jebaraj","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2019.02.003_bib0014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2019.02.003_bib0015","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"The N Engl J Med"},{"key":"10.1016\/j.exphem.2019.02.003_bib0016","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2013-12-543306","article-title":"Mutations in TLR\/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome","volume":"123","author":"Martinez-Trillos","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2019.02.003_bib0017","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2019.02.003_bib0018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.tig.2011.12.002","article-title":"The p53 network: Cellular and systemic DNA damage responses in aging and cancer","volume":"28","author":"Reinhardt","year":"2012","journal-title":"Trends Genet"},{"key":"10.1016\/j.exphem.2019.02.003_bib0019","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3109\/10428194.2013.829919","article-title":"The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia","volume":"55","author":"Stankovic","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2019.02.003_bib0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1078-0432.CCR-16-0594","article-title":"Survival of Del17p CLL depends on genomic complexity and somatic mutation","volume":"23","author":"Yu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2019.02.003_bib0021","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/leu.2014.318","article-title":"The impact of SF3B1 mutations in CLL on the DNA-damage response","volume":"29","author":"Te Raa","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2019.02.003_bib0022","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ccell.2016.10.005","article-title":"Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia","volume":"30","author":"Wang","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2019.02.003_bib0023","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood-2010-08-300160","article-title":"DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing","volume":"117","author":"Mohr","year":"2011","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X19300736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X19300736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:33:49Z","timestamp":1759566829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X19300736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":23,"alternative-id":["S0301472X19300736"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2019.02.003","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of ISEH -- Society for Hematology and Stem Cells.","name":"copyright","label":"Copyright"}]}}